All Q3 FY26 results →
FC

Fineotex Chemical Ltd

Q3 FY26Chemicals & Petrochemicals

Fineotex Chemical Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹47
Market cap₹4.5K Cr
P/E36.8
Updated23 Aug 2026
Read4 min read

The short version

The company expects significant revenue growth driven by multiple segments including textiles, oil & gas, and cleaning & hygiene. Fineotex expects robust long-term growth driven by innovation and operational synergies post-acquisitions.

From Fineotex Chemical Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company expects significant revenue growth driven by multiple segments including textiles, oil & gas, and cleaning & hygiene.
  • Textile segment: Orders have doubled recently with tariff reductions in the U.S., signaling an uptick in demand and expected boom after muted growth in prior quarters.
  • Oil & gas (CrudeChem): Expansion plans underway with capacity and R&D spending of under $10M over 1.5-2 years; the segment is poised for rapid growth with new strategic tie-ups and increased exploration activities globally.
  • Overall, Fineotex aims to become a INR1,000+ crores company in the next financial year, with a medium-term goal of $200 million revenue by 2030 from a base of around $65 million.
  • Volume growth is strong, with a 39% year-on-year increase in Q3 volumes, driven by new customers and expanded product lines.

2 more points from Fineotex Chemical Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Fineotex recently commissioned a new state-of-the-art plant at Ambernath, addressing organic growth needs.
  • Additional capex expected to be moderate, around INR 10-40 crores in the near term for organic expansion.
  • Further investments for CrudeChem’s capacity expansion and R&D planned, totaling less than INR 70-80 crores (under $10 million) over 1.5 to 2 years.
  • CrudeChem is currently debt-free, and Fineotex intends to maintain a disciplined, debt-free capital deployment strategy.

2 more points from Fineotex Chemical Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Textile segment is witnessing an uptick in order books, especially from Indian textile companies supplying to the U.S. market.
  • Orders have doubled recently after import tariff resolutions, signaling growing demand.
  • Major customers like Himatsingka, Indo Count, Vardhman, and Gokaldas are gearing up for increased supplies.
  • Companies in the textile industry are considering expansions over the next 2 years, indicating positive outlook.
  • Cleaning and hygiene segment is stabilizing with new products, expanded sales teams, and bigger accounts being secured.

2 more points from Fineotex Chemical Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Fineotex Chemical Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

  • Jubilant Agri & Consumer Products Ltd (Q3 FY26)

    Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Fineotex Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Fineotex Chemical Ltd Q3 FY26 results?

The company expects significant revenue growth driven by multiple segments including textiles, oil & gas, and cleaning & hygiene. Fineotex expects robust long-term growth driven by innovation and operational synergies post-acquisitions.

What is Fineotex Chemical Ltd share price analysis?

Fineotex Chemical Ltd currently shows a neutral. The stock trades at a P/E of 36.8 with a market cap of ₹4,501 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fineotex Chemical Ltd planning capital expenditure?

Fineotex recently commissioned a new state-of-the-art plant at Ambernath, addressing organic growth needs.

Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.